​
​

Definitive Healthcare (DH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DH Stock Forecast

Definitive Healthcare stock forecast is as follows: an average price target of $9.50 (represents a 117.39% upside from DH’s last price of $4.37) and a rating consensus of 'Hold', based on 12 wall street analysts offering a 1-year stock forecast.

DH Price Target

The average price target for Definitive Healthcare (DH) is $9.50 based on 1-year price targets from 12 Wall Street analysts in the past 3 months, with a price target range of $30.00 to $4.00. This represents a potential 117.39% upside from DH's last price of $4.37.

DH Analyst Ratings

Hold

According to 12 Wall Street analysts, Definitive Healthcare's rating consensus is 'Hold'. The analyst rating breakdown for DH stock is 0 'Strong Buy' (0.00%), 4 'Buy' (33.33%), 7 'Hold' (58.33%), 1 'Sell' (8.33%), and 0 'Strong Sell' (0.00%).

Definitive Healthcare Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 17, 2024David LarsenBTIG--57.66%60.18%
Aug 09, 2024George HillDeutsche Bank--29.20%14.42%
Aug 07, 2024Saket KaliaBarclays--9.59%-8.47%
Aug 06, 2024Craig HettenbachMorgan Stanley--34.41%14.42%
Aug 05, 2024Kash RanganGoldman Sachs--125.35%83.07%
Jul 31, 2024David GrossmanStifel Nicolaus--119.94%71.62%
May 09, 2024Saket KaliaBarclays--30.84%60.18%
May 08, 2024George HillDeutsche Bank--30.84%60.18%
Jan 06, 2023Morgan Stanley--70.29%311.90%
Aug 08, 2022Morgan Stanley--31.89%678.03%
Row per page
Go to

The latest Definitive Healthcare stock forecast, released on Sep 17, 2024 by David Larsen from BTIG, set a price target of $7.00, which represents a 57.66% increase from the stock price at the time of the forecast ($4.44), and a 60.18% increase from DH last price ($4.37).

Definitive Healthcare Price Target by Period

1M3M12M
# Anlaysts-18
Avg Price Target-$7.00$6.31
Last Closing Price$4.37$4.37$4.37
Upside/Downside-100.00%60.18%44.39%

In the current month, the average price target of Definitive Healthcare stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Definitive Healthcare's last price of $4.37. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Nov 08, 2024Canaccord GenuityHoldHoldHold
Sep 17, 2024BTIGBuyInitialise
Aug 09, 2024Deutsche BankHoldHoldHold
Aug 07, 2024BarclaysEqual-WeightEqual-WeightHold
Aug 06, 2024Morgan StanleyEqual-WeightEqual-WeightHold
Aug 05, 2024Goldman SachsNeutralNeutralHold
May 09, 2024BarclaysEqual-WeightEqual-WeightHold
May 08, 2024Deutsche BankHoldHoldHold
Feb 29, 2024Canaccord GenuityPositivePositiveHold
Jan 17, 2024William BlairOutperformOutperformHold
Row per page
Go to

Definitive Healthcare's last stock rating was published by Canaccord Genuity on Nov 08, 2024. The company gave DH a "Hold" rating, the same as its previous rate.

Definitive Healthcare Financial Forecast

Definitive Healthcare Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21
Revenue-------------$65.33M$60.96M$59.20M$60.60M$57.38M$54.55M$50.12M$46.31M$43.08M
Avg Forecast$65.62M$64.17M$63.29M$62.99M$61.44M$60.45M$59.87M$60.06M$60.55M$61.68M$63.10M$63.99M$66.00M$63.70M$61.04M$57.58M$58.45M$56.67M$53.76M$48.52M$44.70M$41.15M
High Forecast$66.65M$65.17M$64.28M$63.98M$62.40M$61.39M$60.81M$61.56M$60.65M$61.74M$63.15M$63.99M$66.16M$63.70M$61.99M$58.48M$59.37M$56.67M$53.76M$48.52M$44.70M$41.15M
Low Forecast$64.98M$63.54M$62.67M$62.38M$60.84M$59.86M$59.29M$58.99M$60.38M$61.62M$63.06M$63.99M$65.75M$63.70M$60.44M$57.02M$57.88M$56.67M$53.76M$48.52M$44.70M$41.15M
# Analysts4444333584749464374347
Surprise %-------------1.03%1.00%1.03%1.04%1.01%1.01%1.03%1.04%1.05%

Definitive Healthcare's average Quarter revenue forecast for Dec 23 based on 9 analysts is $66.00M, with a low forecast of $65.75M, and a high forecast of $66.16M. DH's average Quarter revenue forecast represents a 1.04% increase compared to the company's last Quarter revenue of $65.33M (Sep 23).

Definitive Healthcare EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21
# Analysts4444333584749464374347
EBITDA-------------$-148.09M$7.05M$4.00K$5.39M$12.23M$10.67M$5.48M$8.13M$6.51M
Avg Forecast$-2.03M$-1.98M$-1.96M$-1.95M$-1.90M$-1.87M$-1.85M$-1.86M$-1.87M$-1.91M$-1.95M$7.80M$-2.04M$-1.97M$-1.89M$7.09M$10.28M$14.31M$13.58M$6.45M$11.29M$19.34M
High Forecast$-2.01M$-1.96M$-1.94M$-1.93M$-1.88M$-1.85M$-1.83M$-1.82M$-1.87M$-1.90M$-1.95M$9.36M$-2.03M$-1.97M$-1.87M$8.51M$12.34M$14.31M$13.58M$7.74M$11.29M$23.20M
Low Forecast$-2.06M$-2.01M$-1.99M$-1.98M$-1.93M$-1.90M$-1.88M$-1.90M$-1.87M$-1.91M$-1.95M$6.24M$-2.04M$-1.97M$-1.92M$5.68M$8.23M$14.31M$13.58M$5.16M$11.29M$15.47M
Surprise %-------------75.25%-3.74%0.00%0.52%0.85%0.79%0.85%0.72%0.34%

4 analysts predict DH's average Quarter EBITDA for Sep 23 to be $-1.97M, with a high of $-1.97M and a low of $-1.97M. This is -127.90% lower than Definitive Healthcare's previous annual EBITDA (Jun 23) of $7.05M.

Definitive Healthcare Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21
# Analysts4444333584749464374347
Net Income-------------$-171.53M$-8.57M$-15.60M$6.74M$-6.35M$-9.58M$-13.06M$-14.76M$-15.79M
Avg Forecast$9.96M$10.20M$11.21M$10.06M$9.33M$8.93M$8.60M$8.53M$8.36M$9.32M$9.96M$-7.83M$9.02M$7.07M$7.14M$-7.11M$-12.27M$5.54M$6.18M$-6.47M$4.14M$-10.77M
High Forecast$10.16M$10.41M$11.44M$10.26M$9.52M$9.11M$8.78M$8.70M$8.53M$9.51M$10.04M$-6.26M$10.31M$7.21M$7.28M$-5.69M$-9.82M$5.54M$6.18M$-5.17M$4.14M$-8.62M
Low Forecast$9.83M$10.07M$11.07M$9.93M$9.21M$8.82M$8.49M$7.58M$8.26M$9.21M$9.88M$-9.39M$7.73M$6.98M$7.05M$-8.54M$-14.72M$5.54M$6.18M$-7.76M$4.14M$-12.92M
Surprise %--------------24.27%-1.20%2.19%-0.55%-1.15%-1.55%2.02%-3.56%1.47%

Definitive Healthcare's average Quarter net income forecast for Mar 23 is $-7.11M, with a range of $-8.54M to $-5.69M. DH's average Quarter net income forecast represents a -205.64% decrease compared to the company's last Quarter net income of $6.74M (Dec 22).

Definitive Healthcare SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21
# Analysts4444333584749464374347
SG&A-------------$37.35M$38.37M$37.06M$38.74M$34.90M$32.98M$31.75M$29.02M$22.26M
Avg Forecast$33.98M$33.23M$32.77M$32.62M$31.81M$31.30M$31.00M$31.10M$31.35M$31.94M$32.68M$28.81M$34.18M$32.99M$31.61M$26.19M$36.71M$29.34M$27.84M$23.81M$23.14M$30.05M
High Forecast$34.51M$33.75M$33.29M$33.13M$32.31M$31.79M$31.49M$31.88M$31.40M$31.97M$32.70M$34.57M$34.26M$32.99M$32.10M$31.43M$44.05M$29.34M$27.84M$28.57M$23.14M$36.05M
Low Forecast$33.65M$32.90M$32.45M$32.30M$31.50M$30.99M$30.70M$30.55M$31.26M$31.91M$32.65M$23.05M$34.05M$32.99M$31.30M$20.95M$29.37M$29.34M$27.84M$19.05M$23.14M$24.04M
Surprise %-------------1.13%1.21%1.42%1.06%1.19%1.18%1.33%1.25%0.74%

Definitive Healthcare's average Quarter SG&A projection for Dec 23 is $34.18M, based on 9 Wall Street analysts, with a range of $34.05M to $34.26M. The forecast indicates a -8.49% fall compared to DH last annual SG&A of $37.35M (Sep 23).

Definitive Healthcare EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21
# Analysts4444333584749464374347
EPS-------------$-1.50$-0.08$-0.14$0.06$-0.06$-0.10$-0.13$-0.16$-0.18
Avg Forecast$0.09$0.09$0.10$0.09$0.08$0.08$0.07$0.07$0.07$0.08$0.09$0.08$0.08$0.06$0.06$0.04$0.04$0.05$0.05$0.04$0.04$0.01
High Forecast$0.09$0.09$0.10$0.09$0.08$0.08$0.08$0.07$0.07$0.08$0.09$0.08$0.09$0.06$0.06$0.05$0.04$0.05$0.05$0.04$0.04$0.01
Low Forecast$0.08$0.09$0.10$0.09$0.08$0.08$0.07$0.07$0.07$0.08$0.08$0.08$0.07$0.06$0.06$0.04$0.04$0.05$0.05$0.04$0.04$0.01
Surprise %--------------24.70%-1.25%-3.13%1.53%-1.31%-1.84%-3.67%-4.55%-25.93%

According to 4 Wall Street analysts, Definitive Healthcare's projected average Quarter EPS for Mar 23 is $0.04, with a low estimate of $0.04 and a high estimate of $0.05. This represents a -30.23% decrease compared to DH previous annual EPS of $0.06 (Dec 22).

Definitive Healthcare Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
EVHEvolent Health--263.20%Buy
HCATHealth Catalyst--259.78%Buy
DHDefinitive Healthcare--117.39%Hold
FORAForian--108.33%Buy
CERTCertara--86.58%Buy
PHRPhreesia--82.74%Buy
SLPSimulations Plus--78.80%Buy
PRVAPrivia Health Group--56.86%Buy
HQYHealthEquity---6.95%Buy
HSTMHealthStream---9.91%Buy

DH Forecast FAQ

Is Definitive Healthcare a good buy?

No, according to 12 Wall Street analysts, Definitive Healthcare (DH) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 33.33% of DH's total ratings.

What is DH's price target?

Definitive Healthcare (DH) average price target is $9.5 with a range of $4 to $30, implying a 117.39% from its last price of $4.37. The data is based on 12 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Definitive Healthcare stock go up soon?

According to Wall Street analysts' prediction for DH stock, the company can go up by 117.39% (from the last price of $4.37 to the average price target of $9.5), up by 586.50% based on the highest stock price target, and down by -8.47% based on the lowest stock price target.

Can Definitive Healthcare stock reach $7?

DH's average twelve months analyst stock price target of $9.5 supports the claim that Definitive Healthcare can reach $7 in the near future.

What are Definitive Healthcare's analysts' financial forecasts?

Definitive Healthcare's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $241.82M (high $246.15M, low $238.97M), average EBITDA is $-7.471M (high $-7.383M, low $-7.605M), average net income is $35.39M (high $36.11M, low $34.1M), average SG&A $125.22M (high $127.46M, low $123.75M), and average EPS is $0.304 (high $0.31, low $0.293). DH's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $256.07M (high $260.07M, low $253.57M), average EBITDA is $-7.911M (high $-7.834M, low $-8.035M), average net income is $41.43M (high $42.27M, low $40.91M), average SG&A $132.6M (high $134.67M, low $131.31M), and average EPS is $0.356 (high $0.363, low $0.351).

Did the DH's actual financial results beat the analysts' financial forecasts?

Based on Definitive Healthcare's last annual report (Dec 2022), the company's revenue was $222.65M, beating the average analysts forecast of $217.39M by 2.42%. Apple's EBITDA was $33.77M, missing the average prediction of $44.62M by -24.33%. The company's net income was $-22.255M, beating the average estimation of $-7.015M by 217.26%. Apple's SG&A was $138.37M, beating the average forecast of $117.7M by 17.56%. Lastly, the company's EPS was $-0.22, missing the average prediction of $0.177 by -224.35%. In terms of the last quarterly report (Sep 2023), Definitive Healthcare's revenue was $65.32M, beating the average analysts' forecast of $63.7M by 2.55%. The company's EBITDA was $-148M, beating the average prediction of $-1.968M by 7424.68%. Definitive Healthcare's net income was $-172M, missing the average estimation of $7.07M by -2526.60%. The company's SG&A was $37.35M, beating the average forecast of $32.99M by 13.22%. Lastly, the company's EPS was $-1.5, missing the average prediction of $0.0607 by -2569.70%